Ebselen Improves Ischemia-Reperfusion Injury After Rat Lung Transplantation

Hamacher, Jürg; Stammberger, Uz; Weber, Elvira; Lucas, Rudolf; Wendel, Albrecht

Ebselen Improves Ischemia-Reperfusion Injury After Rat Lung Transplantation

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

2009

Autor:innen

Hamacher, Jürg

Stammberger, Uz

Weber, Elvira

Lucas, Rudolf

Wendel, Albrecht

DOI (zitierfähiger Link)

https://doi.org/10.1007/s00408-009-9134-x

Sammlungen

Biologie

Publikationstyp

Zeitschriftenartikel

Publikationsstatus

Published

Erschienen in

Lung. Springer. 2009, 187(2), pp. 98-103. ISSN 0341-2040. eISSN 1432-1750. Available under: doi: 10.1007/s00408-009-9134-x

Zusammenfassung

The heterocyclic organic compound ebselen (2-phenyl-1,2-benizsoselenazol-3(2H)-one) is a glutathione peroxidase mimick with protective properties against oxidative injury. Ebselen also has anti-inflammatory activity, including attenuation of tumor necrosis factor release and increase of interleukin-10, as shown in vivo, in inflammatory and ischemia-reperfusion injuries, including those of the lung. This study was designed to assess its effect on severe ischemia-reperfusion injury in a model of left-sided rat lung isotransplantation. Orthotopic single left-sided lung allotransplantation (Wistar to Wistar) was performed in female rats after a total ischemic time of 18 h. In nine recipients given 500 mg/kg oral ebselen 1 h before transplantation, graft PaO2/FiO2 was improved 24 h after transplantation, as evidenced with a mean (standard deviation) PaO2 of 139 (61) mmHg vs. eight controls with 65 (33) mmHg (p = 0.009). Bronchoalveolar PMN count was reduced to approximately 50% in the ebselen group compared with controls, whereas no difference in the tumor necrosis factor content was found. We conclude that the improvement of lung function in ebselen-treated transplanted rats is mainly the result of the anti-inflammatory activity of the drug during reperfusion.

Fachgebiet (DDC)

570 Biowissenschaften, Biologie

Zitieren

ISO 690

HAMACHER, Jürg, Uz STAMMBERGER, Elvira WEBER, Rudolf LUCAS, Albrecht WENDEL, 2009. Ebselen Improves Ischemia-Reperfusion Injury After Rat Lung Transplantation. In: Lung. Springer. 2009, 187(2), pp. 98-103. ISSN 0341-2040. eISSN 1432-1750. Available under: doi: 10.1007/s00408-009-9134-x

BibTex

@article{Hamacher2009Ebsel-58127,
  year={2009},
  doi={10.1007/s00408-009-9134-x},
  title={Ebselen Improves Ischemia-Reperfusion Injury After Rat Lung Transplantation},
  number={2},
  volume={187},
  issn={0341-2040},
  journal={Lung},
  pages={98--103},
  author={Hamacher, Jürg and Stammberger, Uz and Weber, Elvira and Lucas, Rudolf and Wendel, Albrecht}
}

RDF

<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/58127">
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/58127"/>
    <dcterms:abstract xml:lang="eng">The heterocyclic organic compound ebselen (2-phenyl-1,2-benizsoselenazol-3(2H)-one) is a glutathione peroxidase mimick with protective properties against oxidative injury. Ebselen also has anti-inflammatory activity, including attenuation of tumor necrosis factor release and increase of interleukin-10, as shown in vivo, in inflammatory and ischemia-reperfusion injuries, including those of the lung. This study was designed to assess its effect on severe ischemia-reperfusion injury in a model of left-sided rat lung isotransplantation. Orthotopic single left-sided lung allotransplantation (Wistar to Wistar) was performed in female rats after a total ischemic time of 18 h. In nine recipients given 500 mg/kg oral ebselen 1 h before transplantation, graft PaO2/FiO2 was improved 24 h after transplantation, as evidenced with a mean (standard deviation) PaO2 of 139 (61) mmHg vs. eight controls with 65 (33) mmHg (p = 0.009). Bronchoalveolar PMN count was reduced to approximately 50% in the ebselen group compared with controls, whereas no difference in the tumor necrosis factor content was found. We conclude that the improvement of lung function in ebselen-treated transplanted rats is mainly the result of the anti-inflammatory activity of the drug during reperfusion.</dcterms:abstract>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:creator>Hamacher, Jürg</dc:creator>
    <dcterms:title>Ebselen Improves Ischemia-Reperfusion Injury After Rat Lung Transplantation</dcterms:title>
    <dc:contributor>Weber, Elvira</dc:contributor>
    <dc:language>eng</dc:language>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Stammberger, Uz</dc:contributor>
    <dc:creator>Weber, Elvira</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Stammberger, Uz</dc:creator>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-07-22T07:32:23Z</dc:date>
    <dc:creator>Wendel, Albrecht</dc:creator>
    <dc:contributor>Lucas, Rudolf</dc:contributor>
    <dc:creator>Lucas, Rudolf</dc:creator>
    <dc:contributor>Wendel, Albrecht</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-07-22T07:32:23Z</dcterms:available>
    <dcterms:issued>2009</dcterms:issued>
    <dc:contributor>Hamacher, Jürg</dc:contributor>
  </rdf:Description>
</rdf:RDF>

Universitätsbibliographie

Ja

Begutachtet

Ja